AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy

All NewsOctober 6, 2025

AstraZeneca and Daiichi Sankyo’s Datroway improved survival outcomes over chemotherapy in advanced triple-negative breast cancer patients.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent